Work

Table S6 from Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations

Year: 2023

Type: other

Abstract: Deletions identified by LentiMutate on BCR-ABL cDNA and imatinib in the K562 cell line. Nucleotide position refers to the position within full length BCR-ABL (p210). Values from individual biological replicates are shown.

DOI: 10.1158/0008-5472.22362342.v1

Authors: Paul Yenerall, Rahul K. Kollipara, Kimberley Avila, Michael Peyton, Christopher A. Eide, Daniel Bottomly, Shannon K. McWeeney, Yan Liu, Kenneth D. Westover, Brian J. Druker, John D. Minna, Ralf Kittler

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361266586

Cites:

Cited by:

Related to: 10